Anti-Human IL5 Therapeutic Antibody (Reslizumab)

Recombinant monoclonal antibody to IL5. Reslizumab is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.
Supplier Creative Biolabs
Product # TAB-136
Pricing Inquiry
Host Rat
Target IL5
Species Reactivity Human
Type IgG4
Applications Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
Storage Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles.
Feedback